Cancer vaccine strategies get bigger and better

Article Abstract:

A properly designed cancer vaccine can be very effective, as shown by a study of 20 lymphoma patients who were given granulocyte-macrophage colony stimulating factor in addition to the cancer vaccine. GM-CSF promotes the presentation of the tumor antigen to cytotoxic T cells.

---

Prime boost vaccines power up in people

Article Abstract:

Vaccines that use DNA for priming and recombinant modified vaccinia Ankara virus (MVA) for boosting show great promise in pre-clinical models. This heterologous prime-boost protocol that is used in human trials is discussed.

Clinical trials, Vaccines

---

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

Article Abstract:

For the preparation of cancer vaccines, fusion of tumor cells with antigen-presenting cells has been used. Characterization of cell fusion, which helps in identification, is discussed.

Product development, Analysis, Usage, Cell interaction, Cell interactions, Tumors, Plant, Plant tumours, Plant tumors

Similar abstracts:

• Abstracts: Cancer stem cells: Models and concepts. The biomedical challenges of space flight
• Abstracts: Emerging therapeutics for chronic Hepatitis B. Prostatitis/Chronic pelvic pain syndrome. Open surgical repair versus endovascular therapy for chronic lower-extremity occlusive disease
• Abstracts: Human susceptibility and resistance to Norwalk virus infection. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
• Abstracts: Advances in detecting and responding to threats from bioterrorism and emerging infectious disease. 'New variant' Creutzfeldt-Jakob disease and bovine spongiform encephalopathy
• Abstracts: ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. A peptide inhibitor of c-Jun N-terminal kinase proyects against excitotoxicity and cerebral ischemia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.